Company 2cureX AB

Equities

2CUREX

SE0010468124

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Annual profits - Rate of surprise

Sector Bio Diagnostics & Testing

Market Closed - Nasdaq Stockholm Other stock markets 06:58:21 2024-04-25 am EDT			5-day change	1st Jan Change
0.47 ^SEK	+7.06%		+10.85%	-76.62%

Feb. 29	2curex AB Elects Grith Hagel as a New Board Member	CI
Feb. 22	2cureX AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

2cureX AB is a Sweden-based company engaged in the biotechnology sector. The Company focuses on the research and development of diagnostic substances to select treatment for cancer patients. The Company's product candidate, IndiTreat - CRC, aims at optimizing medical treatment for the colorectal cancer patients. Through IndiTreat - CRC, healthcare professionals collect a tumor sample from patients to create a number of three-dimensional micro tumors in order to test available chemotherapies and experimental treatments. The Company's product pipeline includes also IndiTreat - OVA, targeting ovarian cancer treatment, and IndiTreat - KDN, focusing on kidney cancer treatment. It operates through 2cureX A/S.

Number of employees: 14

Managers	Title	Age	Since
Kenneth Graabek Johansen CEO	Chief Executive Officer	48	21-01-31
Grith Hagel FOU	Founder	65	05-12-31
Ole Thastrup FOU	Founder	71	05-12-31
Raphael Gruber CTO	Chief Tech/Sci/R&D Officer	60	22-06-30
Jacob Thastrup PRN	Corporate Officer/Principal	-	-
Tabea Sturmheti PRN	Corporate Officer/Principal	39	16-12-31
Jesper Kristiansen PRN	Corporate Officer/Principal	59	21-07-31
Manuel Fernández LAW	General Counsel	-	22-04-20

Members of the board	Title	Age	Since
Ole Thastrup FOU	Founder	71	05-12-31
Tonni Bülow-Nielsen CHM	Chairman	-	Nov. 13

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	17,602,916	7,467,585 ( 42.42 %)	0	42.42 %

2cureX AB

Fruebjergvej 3

2100, Copenhagen

+45 22 11 53 99

http://www.2curex.com

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Diagnostics & Testing

	1st Jan change	Capi.
2CUREX AB	-76.62%	710K
EXACT SCIENCES CORPORATION	-20.53%	11.48B
IOVANCE BIOTHERAPEUTICS, INC.	+41.94%	3.27B
GUARDANT HEALTH, INC.	-36.56%	2.2B
BGI GENOMICS CO., LTD.	-18.92%	2.05B
VERACYTE, INC.	-29.19%	1.49B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+15.73%	1.01B
SEEGENE, INC.	-4.37%	743M
CAREDX, INC	-37.00%	413M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-46.73%	377M

Bio Diagnostics & Testing